新的活性粘胶补充剂在骨关节炎实验模型行为中的有效性。

Q3 Medicine
R E Pérez Expósito, M A Ortega Núñez, M J Buján Varela, R M Vega Rodríguez, A I Ortíz Chércoles, B J De La Torre Escuredo
{"title":"新的活性粘胶补充剂在骨关节炎实验模型行为中的有效性。","authors":"R E Pérez Expósito, M A Ortega Núñez, M J Buján Varela, R M Vega Rodríguez, A I Ortíz Chércoles, B J De La Torre Escuredo","doi":"10.1016/j.recot.2024.12.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To evaluate with an animal model of osteoarthritis (New Zealand rabbits) the effectiveness of treatment with active viscosupplements (hyaluronic acid loaded with nanoparticles (NPs) that encapsulate anti-inflammatory compounds or drugs.</p><p><strong>Material and methods: </strong>Experimental study composed of 5 groups of rabbits in which section of the anterior cruciate ligament and resection of the internal meniscus were performed to trigger degenerative changes and use it as a model of osteoarthritis. The groups were divided into osteoarthrosis without treatment (I), treatment with commercial hyaluronic acid (HA) (II), treatment with HA with empty nanoparticles (III), treatment with HA with nanoparticles encapsulating dexamethasone (IV) and treatment with HA with nanoparticles that encapsulate curcumin (V). In groups II-V, the infiltration of the corresponding compound was carried out spaced one week apart. Macroscopic histological analysis was performed using a scale based on the Outerbridge classification for osteoarthritis.</p><p><strong>Results: </strong>We observed that this osteoarthritis model is reproducible and degenerative changes similar to those found in humans are observed. The groups that were infiltrated with hyaluronic acid with curcumin-loaded nanoparticles (V), followed by the dexamethasone group (IV) presented macroscopically less fibrillation, exposure of subchondral bone and sclerosis (better score on the scale) than the control groups (I) (osteoarthritis without treatment), group (II) treated with commercial hyaluronic acid and hyaluronic acid with nanoparticles without drug (III).</p><p><strong>Conclusions: </strong>The use of active viscosupplements could have an additional effect to conventional hyaluronic acid treatment due to its antioxidant and anti-inflammatory effect. The most promising group was hyaluronic acid with nanoparticles that encapsulate curcumin and the second group was the one that encapsulates dexamethasone.</p>","PeriodicalId":39664,"journal":{"name":"Revista Espanola de Cirugia Ortopedica y Traumatologia","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Translated article] Efficacy of new active viscosupplements on the behaviour of an experimental model of osteoarthritis.\",\"authors\":\"R E Pérez Expósito, M A Ortega Núñez, M J Buján Varela, R M Vega Rodríguez, A I Ortíz Chércoles, B J De La Torre Escuredo\",\"doi\":\"10.1016/j.recot.2024.12.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To evaluate with an animal model of osteoarthritis (New Zealand rabbits) the effectiveness of treatment with active viscosupplements (hyaluronic acid loaded with nanoparticles (NPs) that encapsulate anti-inflammatory compounds or drugs.</p><p><strong>Material and methods: </strong>Experimental study composed of 5 groups of rabbits in which section of the anterior cruciate ligament and resection of the internal meniscus were performed to trigger degenerative changes and use it as a model of osteoarthritis. The groups were divided into osteoarthrosis without treatment (I), treatment with commercial hyaluronic acid (HA) (II), treatment with HA with empty nanoparticles (III), treatment with HA with nanoparticles encapsulating dexamethasone (IV) and treatment with HA with nanoparticles that encapsulate curcumin (V). In groups II-V, the infiltration of the corresponding compound was carried out spaced one week apart. Macroscopic histological analysis was performed using a scale based on the Outerbridge classification for osteoarthritis.</p><p><strong>Results: </strong>We observed that this osteoarthritis model is reproducible and degenerative changes similar to those found in humans are observed. The groups that were infiltrated with hyaluronic acid with curcumin-loaded nanoparticles (V), followed by the dexamethasone group (IV) presented macroscopically less fibrillation, exposure of subchondral bone and sclerosis (better score on the scale) than the control groups (I) (osteoarthritis without treatment), group (II) treated with commercial hyaluronic acid and hyaluronic acid with nanoparticles without drug (III).</p><p><strong>Conclusions: </strong>The use of active viscosupplements could have an additional effect to conventional hyaluronic acid treatment due to its antioxidant and anti-inflammatory effect. The most promising group was hyaluronic acid with nanoparticles that encapsulate curcumin and the second group was the one that encapsulates dexamethasone.</p>\",\"PeriodicalId\":39664,\"journal\":{\"name\":\"Revista Espanola de Cirugia Ortopedica y Traumatologia\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Espanola de Cirugia Ortopedica y Traumatologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.recot.2024.12.009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Espanola de Cirugia Ortopedica y Traumatologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.recot.2024.12.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:用新西兰兔骨关节炎动物模型评价活性粘质补充剂(透明质酸纳米颗粒)包封抗炎化合物或药物治疗的有效性。材料与方法:实验研究5组兔,切除前交叉韧带,切除内半月板,引发退行性改变,作为骨关节炎模型。各组分为未治疗骨关节病组(I)、透明质酸组(II)、透明质酸空纳米颗粒组(III)、透明质酸纳米颗粒包封地塞米松组(IV)和透明质酸纳米颗粒包封姜黄素组(V)。在II至V组中,相应化合物的浸润间隔一周进行。采用基于Outerbridge骨性关节炎分级的量表进行宏观组织学分析。结果:我们观察到这种骨关节炎模型是可复制的,并且观察到与人类相似的退行性变化。含姜黄素纳米颗粒透明质酸浸润组(V),其次是地塞米松组(IV),与对照组(I组)(未治疗骨关节炎)、市配透明质酸组(II组)和透明质酸纳米颗粒无药物治疗组(III组)相比,宏观上纤颤、软骨下骨暴露和硬化症(评分更高)较少。由于其抗氧化和抗炎作用,活性粘质补充剂的使用可能比传统的透明质酸治疗有额外的效果。最有希望的一组是透明质酸纳米颗粒包裹姜黄素,第二组是包裹地塞米松。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[Translated article] Efficacy of new active viscosupplements on the behaviour of an experimental model of osteoarthritis.

Objective: To evaluate with an animal model of osteoarthritis (New Zealand rabbits) the effectiveness of treatment with active viscosupplements (hyaluronic acid loaded with nanoparticles (NPs) that encapsulate anti-inflammatory compounds or drugs.

Material and methods: Experimental study composed of 5 groups of rabbits in which section of the anterior cruciate ligament and resection of the internal meniscus were performed to trigger degenerative changes and use it as a model of osteoarthritis. The groups were divided into osteoarthrosis without treatment (I), treatment with commercial hyaluronic acid (HA) (II), treatment with HA with empty nanoparticles (III), treatment with HA with nanoparticles encapsulating dexamethasone (IV) and treatment with HA with nanoparticles that encapsulate curcumin (V). In groups II-V, the infiltration of the corresponding compound was carried out spaced one week apart. Macroscopic histological analysis was performed using a scale based on the Outerbridge classification for osteoarthritis.

Results: We observed that this osteoarthritis model is reproducible and degenerative changes similar to those found in humans are observed. The groups that were infiltrated with hyaluronic acid with curcumin-loaded nanoparticles (V), followed by the dexamethasone group (IV) presented macroscopically less fibrillation, exposure of subchondral bone and sclerosis (better score on the scale) than the control groups (I) (osteoarthritis without treatment), group (II) treated with commercial hyaluronic acid and hyaluronic acid with nanoparticles without drug (III).

Conclusions: The use of active viscosupplements could have an additional effect to conventional hyaluronic acid treatment due to its antioxidant and anti-inflammatory effect. The most promising group was hyaluronic acid with nanoparticles that encapsulate curcumin and the second group was the one that encapsulates dexamethasone.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
156
审稿时长
51 weeks
期刊介绍: Es una magnífica revista para acceder a los mejores artículos de investigación en la especialidad y los casos clínicos de mayor interés. Además, es la Publicación Oficial de la Sociedad, y está incluida en prestigiosos índices de referencia en medicina.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信